BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

Abstract

The British Association for Psychopharmacology guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric
disorders primarily focus on their pharmacological management. They are based explicitly on the available evidence and presented as recommendations
to aid clinical decision making for practitioners alongside a detailed review of the evidence. A consensus meeting, involving experts in the treatment of
these disorders, reviewed key areas and considered the strength of the evidence and clinical implications. The guidelines were drawn up after feedback
from participants. The guidelines primarily cover the pharmacological management of withdrawal, short- and long-term substitution, maintenance of
abstinence and prevention of complications, where appropriate, for substance abuse or harmful use or addiction as well management in pregnancy,
comorbidity with psychiatric disorders and in younger and older people.

More information

Identifiers

Catalogue record

Export record

ASCII CitationAtomBibTeXData Cite XMLDublin CoreDublin CoreEP3 XMLEndNoteHTML CitationHTML CitationHTML ListJSONMETSMODSMPEG-21 DIDLOpenURL ContextObjectOpenURL ContextObject in SpanRDF+N-TriplesRDF+N3RDF+XMLRIOXX2 XMLReferReference ManagerSimple Metadata

Altmetrics